![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 215/56 | (2006.01) |
Y10T 428/2982 | (2015.01) | ||
A61K 31/47 | (2006.01) | ||
A61K 31/47 | (2013.01) | ||
C07D 215/56 | (2013.01) | ||
A61P 1/00 | (2018.01) | ||
A61P 1/12 | (2018.01) | ||
A61P 1/18 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 13/02 | (2018.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 19/08 | (2018.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 21/02 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 25/08 | (2018.01) | ||
A61P 25/14 | (2018.01) | ||
A61P 25/16 | (2018.01) | ||
A61P 25/28 | (2018.01) | ||
A61P 27/02 | (2018.01) | ||
A61P 27/04 | (2018.01) | ||
A61P 3/00 | (2018.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 3/06 | (2018.01) | ||
A61P 37/06 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 5/00 | (2018.01) | ||
A61P 5/14 | (2018.01) | ||
A61P 5/16 | (2018.01) | ||
A61P 7/00 | (2018.01) | ||
A61P 7/04 | (2018.01) | ||
A61P 7/06 | (2018.01) | ||
A61P 7/10 | (2018.01) | ||
A61P 7/12 | (2018.01) | ||
A61P 3/10 | (2018.01) |
(11) | Patento numeris | 3708564 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20156047.1 |
Europos patento paraiškos padavimo data | 2006-12-28 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-09-16 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-10-09 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
754381 P | 2005-12-28 | US |
(72) |
HURTER, Patricia , US
GONG, Yuchuan , US
YOUNG, Christopher R. , US
CONNELLY, Patrick , US
ROWE, William , US
COSTACHE, Adriana , US
KRAWIEC, Mariusz , US
FENG, Yushi , US
TRUDEAU, Martin , CA
|
(73) |
Vertex Pharmaceuticals Incorporated ,
50 Northern Avenue, Boston, MA 02210,
US
|
(54) | A SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |
A SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |